在血小板中USP25介导的塔林-1稳定:在衰老过程中产生高反应和血栓形成风险的新机制
Xuemei Jia1, Shuoyi Jiang2, Hong Cheng3
1Huashan Hospital, Fudan University, Shanghai, China.
Blood
|September 25, 2025
概括
衰老会增加血小板的反应性和血栓形成的风险. 这项研究显示,老年血小板的泛化减少,与高调的USP25有关,该USP25稳定了塔林-1,增强了血小板过活性. 抑制USP25可以减少这种年龄相关的效应.
科学领域:
- 生物遗传学 生物遗传学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 衰老是血小板过度反应和血栓形成的主要危险因素.
- 与年龄相关的血小板功能障碍背后的分子机制尚未完全理解.
- 基化在调节蛋白质功能和稳定性方面起着至关重要的作用.
研究的目的:
- 为了研究在与年龄相关的血小板过敏反应中,无化作用的作用.
- 为了确定涉及血小板衰老的特定二化酶 (DUB).
- 阐明USP25影响血小板功能和衰老中的血栓形成的机制.
主要方法:
- 在老年和年轻血小板中蛋白质基因分析用乌比奎丁修饰的蛋白质.
- 西方斑点分析以量化蛋白质表达和无处不在水平.
- 功能性血小板检测,动脉血栓形成模型和质谱学.
主要成果:
- 陈旧的血小板表现出降低的整体无处不在和增加的DUBs的表达,包括USP25.
- 缺乏USP25会损害血小板功能,并延迟血栓的形成.
- USP25通过二基化稳定了塔林-1,导致了血小板过活.
- 在老年模型中,USP25/28抑制剂AZ1抑制了血小板过度反应.
结论:
- 血小板无化在衰老过程中被重塑.
- 通过USP25介导的塔林-1稳定是驱动老年人血小板过活性的关键机制.
- 用像AZ1这样的抑制剂向USP25可能提供治疗策略,以减轻年龄相关的血栓形成风险.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Formation of the Platelet Plug
8.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.7K
Intracellular Signaling Affects Focal Adhesions
3.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.5K
Structure and Function of Platelets
3.0K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.0K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Clot Retraction and Fibrinolysis
8.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.5K


